0

Urinary Tract Cancer Market Expected to Reach $8.786 Billion by 2030—Allied Market Research

 
2022
Urinary Tract Cancer Market

Report Code : A00493

quote “Alarming rise in prevalence of bladder cancer across the globe, increase in geriatric population, advancements in R&D activities in healthcare, rise in number of approvals of drug therapy for treatment of urinary tract cancer, and surge in number of smokers are expected to notably contribute toward the growth of the global urinary tract cancer market during the forecast period.” quote

Onkar Sumant
Manager, Healthcare at Allied Market Research

Get 20% Free Customization In This Report
Follow us on Social Media:       
 

According to a new report published by Allied Market Research, titled, “Urinary tract cancer Market by Cancer Type, Treatment Type, and Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021–2030," the global urinary tract cancer market was valued at $1.704 billion in 2020, and is estimated to reach $8.786 billion by 2030, growing at a CAGR of 18.6% from 2021 to 2030.

Cancer is defined as an adverse disease that is caused due to abnormal cell growth, and possess the potential to spread to other body parts. Urinary tract cancer is a type of cancer found in the bladder, ureter, and urethra. The most common urinary tract cancer is bladder cancer. The aging population, smokers and workers in the chemical industry are more vulnerable to urinary tract infection.

The factors that drive the growth of the urinary tract cancer market include rise in prevalence of urinary tract cancer, such as bladder cancer; increase in number of geriatric population; advancement in R&D activities in healthcare sectors, and surge in the development of advanced biologic therapy. For instance, according to the Centers for Disease Control and Prevention (CDC), around 17,500 women, and 56,000 men are diagnosed with bladder cancer, every year in the U.S. The geriatric population is more prone to bladder cancer due to weakening of immune cells against the cancer tissue present in the bladder. According to American Cancer Society, it was observed that about 9 out of 10 people with bladder cancer, are above the age of 55. Market players are focusing on the development of novel therapies for treatment of urinary tract cancer. Moreover, in January 2021, Merck and Pfizer Inc., announced the European Commission approval of Bavencio (avelumab) which is the first line treatment of advanced or metastatic urothelial carcinoma. Furthermore, in March 2021, Exelixis, Inc., a genomic based drug discovery company, announced the clinical trial collaboration and agreement with Merck KGaA, and Pfizer in order to evaluate XL092 and avelumab in different forms of locally advanced or metastatic urothelial carcinoma.

Increase in prevalence of urinary tract infection, rise in number of smokers, and surge in medical tourism are anticipated to drive the growth of the urinary tract cancer market. In addition, increasing numbers of bladder cancer research centers has led to the development of innovative technologies and advanced therapy in the healthcare for treatment of urinary tract cancer, thereby propelling the growth of the market.

Moreover, initiatives taken by governments for development of the healthcare infrastructure and rise in awareness about and treatment of cancer are the key factors that boost the growth of the market. Furthermore, an increase in the cost of healthcare and surge in the number of funding for various research centers propel the growth of the market. In addition, surge in number of workers in chemical industry fuel the market growth. These workers are more prone to urinary tract cancer, due to prolonged exposure to various chemical.

The urinary tract cancer market is segmented on the basis of cancer type, treatment type, distribution channel, and region. On the basis of cancer type, the market is divided into bladder cancer, urethral cancer and ureteric and renal pelvic cancer. The bladder cancer segment dominated the market in 2020, and is expected to continue this trend during the forecast period, owing to increase in healthcare expenditure, advancement in available therapies, and increase in prevalence of bladder cancer.

On the basis of treatment type, the market is classified into chemotherapy, and immunotherapy. The immunotherapy segment dominated the market in 2020, and is expected to continue this trend during the forecast period, owing to increase in incidence of cancer, a rise in the number of approvals, stringent government regulation and increase in number of smokers. On the basis of distribution channel, the market is classified into retail pharmacy, and online pharmacy. The retail pharmacy segment dominated the market in 2020, and is expected to continue this trend during the forecast period, owing to increase in number of hospital & oncology centers, rise in prevalence of cancer and rise in the number of drug approval for treatment of cancer.

The COVID-19 outbreak is anticipated to have a negative impact on growth of the global urinary tract cancer market. The COVID-19 pandemic has stressed the healthcare systems in the world. Most hospital and cancer centers have reduced their outpatient capacity and conducting a triage to only select the patients that are in most need of a cystoscopy. This leads to cancellation of many non-essential surgical procedures across the world. A huge number of clinics, hospitals across the globe, were restructured to increase the hospital capacity for the patient diagnosed with COVID-19. According to Future Science OA, in September 2020, it was observed that the admission of a patient for urology, oncology or radiotherapy departments are avoided. Subsequently, this leads to decrease in demand for available therapy of urinary tract cancer and decrease the growth of the market.

KEY FINDINGS OF THE STUDY

  • By cancer type, the bladder cancer segment was the highest contributor to the market in 2020.
  • By treatment type, the immunotherapy segment was the highest contributor to the market in 2020.
  • By distribution channel, the retail pharmacy segment dominated the market in 2020 and is expected to continue this trend during the forecast period.
  • By region, North America garnered the largest revenue share in 2020, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.

North America accounted for a majority of the global urinary tract cancer market share in 2020 and is anticipated to remain dominant during the forecast period. This is attributed to rise in prevalence of bladder cancer, an increase in healthcare expenditure, the presence of key players, availability of advanced therapy for cancer treatment, and advancement in R&D activities in healthcare sector in the region. Asia-Pacific is anticipated to witness lucrative growth, owing to increase in prevalence of urinary tract cancer, a rise in the number of smokers, initiative taken by the government and surge in in number geriatric population.

Need More Information

pr-det-talk Talk to David (Europe)

pr-det-talk Talk to Sona Padman (Americas)

5933 NE Win Sivers Drive #205,
Portland, OR 97220 United States

pr-det-phone Toll Free: +1-800-792-5285

pr-det-phone UK: +44-845-528-1300

pr-det-phone Hong Kong: +852-301-84916

pr-det-phone India (Pune): +91 2066346060

pr-det-phone Fax: +1(855) 550-5975

pr-det-phone help@alliedmarketresearch.com

 

For Media Inquiries, Please Contact

Allied Market Research
Contact Toll Free: +1-800-792-5285
Drop us an email at
media@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Request Free Sample
 
 

First time buyer?
Check offers and discount on this report
To get this report

Click Here
 
 

quote Urinary Tract Cancer Market by Cancer type (Bladder Cancer, Urethral cancer and Ureteric and Renal Pelvic Cancer), Treatment Type (Chemotherapy, and Immunotherapy), and Distribution Channel (Retail Pharmacy, and Online Pharmacy): Global Opportunity Analysis and Industry Forecast, 2021––2030 quote

View Report
 
 

Avenue: Entire Library membership of Allied Market Research Reports at your disposal

  • Avenue is an innovative subscription-based online report database.
  • Avail an online access to the entire library of syndicated reports on more than 2,000 niche industries and company profiles on more than 12,000 firms across 11 domains.
  • A cost-effective model tailored for entrepreneurs, investors, and students & researchers at universities.
  • Request customizations, suggest new reports, and avail analyst support as per your requirements.
  • Get an access to the library of reports at any time from any device and anywhere.

 
 

WHY ALLIED MARKET RESEARCH?

INFLALLIBLE METHODOLOGY

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

ANALYST SUPPORT

For complete satisfaction

CUSTOMIZATION

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 

Featured Readings

 
rep-img

Published Date Dec 2024

Dump Truck Market

Download Sample
rep-img

Published Date Nov 2024

Alloys Market

Download Sample
rep-img

Published Date Nov 2024

Aerospace Sealants Market

Download Sample

Buy Full Version
"Urinary Tract Cancer Market"
Purchase Enquiry

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of the scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save the time of readers